About Prof. Dr. Antonio Pezzutto
- Prof. Dr. Antonio Pezzutto is a Hematologist in Berlin, Germany with a thriving experience of over 42+ years.
- He completed his graduation from the University of Padova Medical School, Padova, Italy in 1972 and laster did his specialty training from the University of Heidelberg in 1983.
- His areas of interest are management of leukemias and lymphoma, evaluation and management of bleeding disorders, blood clots, stem cell transplant (autologous, allogenic & umbilical cord blood transplant), etc.
- Being a keen academician, he has worked as a resident in prestigious institutions such as the University of Padova Medical School and the University of Heidelberg.
- He has won several national and international awards along with speaking at many conferences and gatherings about hematological disorders and cancer.
Hospital
Charite University Hospital
Location
Berlin, Germany
Special Interest
Autologous transplant for multiple myeloma Hemoglobinopathies Bone marrow transplant for thalassemias and sickle cell disease Bone marrow failure syndrome Management of clots and Bleeding problems Immunodeficiency work up
Work Experience of Prof. Dr. Antonio Pezzutto
Senior Resident, University of Heidelberg
Senior Resident, University of Padova Medical School
Prof. Dr. Antonio Pezzutto's
- Graduation, 1983, University of Padova Medical School, Padova, Italy
- Post Graduation, 1972, University of Heidelberg
- Westermann, J., Flörcken, A., Willimsky, G., van Lessen, A., Kopp, J., Takvorian, A., Jöhrens, K., Lukowsky, A., Schönemann, C., Sawitzki, B., Pohla, H., Frank, R., Dörken, B., Schendel, D. J., Blankenstein, T. & Pezzutto, A. (2011). Allogeneic gene-modified tumor cells (RCC-26/IL-7/CD80) as a vaccine in patients with metastatic renal cell cancer: a clinical phase-I study. Gene Ther, 4, 354-63
- Westermann, J., Kopp, J., van Lessen, A., Hecker, A. C., Baskaynak, G., le Coutre, P., Döhner, K., Döhner, H., Dörken, B. & Pezzutto, A. (2007). Vaccination with autologous non-irradiated dendritic cells in patients with bcr/abl+ chronic myeloid leukaemia. Br J Haematol, 4, 297-306.
- Westermann, J., Nguyen-Hoai, T., Baldenhofer, G., Höpken, U. E., Lipp, M., Dörken, B. & Pezzutto, A. (2007). CCL19 (ELC) as an adjuvant for DNA vaccination: induction of a TH1-type T-cell response and enhancement of antitumor immunity. Cancer Gene Ther, 6, 523-32.
Wondering where to start?
(Get Free opinion, Quote, Medical Visa Invitation and Assistance at every step of your treatment.)
Doctor Similar to Prof. Dr. Antonio Pezzutto in Berlin
Prof. Dr. Ernst Spath-Schwalbe
Hematologist
Director
Graduation
Berlin, Germany
35 years of experience
Vivantes Hospital Group
Dr. Christian Scholz
Hematologist
Director
Fellowship,Graduation
Berlin, Germany
29 years of experience
Vivantes Hospital Group
Prof. Dr. Ulrich Keller
Hematologist
Director
Graduation
Berlin, Germany
23 years of experience
Charite University Hospital
Dr. Veit Mansmann
Hematologist
Director
Fellowship,Graduation
Berlin, Germany
22 years of experience